Previous 10 | Next 10 |
2024-04-18 06:21:01 ET Read the full article on Seeking Alpha For further details see: Ocugen stock jumps after $175M securities filing
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Ocugen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 14, 2024) - Faruqi & Faruqi, LLP, a leading national se...
2024-04-12 14:30:00 ET Summary Introducing a new recurring series to help you sift through ideas and data on the site: The "Undercovered" Dozen. In this monthly series, we'll cover twelve ideas from the previous month on stocks that receive limited coverage across Seeking Alpha. ...
NEW YORK, NY / ACCESSWIRE / April 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ocugen, Inc. ("Ocugen" or "the Company") (NASDAQ:OCGN). Investors who purchased Ocugen securities are encouraged to obtain additional information and a...
2024-04-10 10:20:34 ET More on Ocugen Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues Ocugen stock gains after FDA nod to initiate Phase 3 trial of gene therapy candidate Ocugen advances Phase 1/2 trial for eye disease candidat...
MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Committee for...
2024-04-08 07:10:32 ET Ocugen ( NASDAQ: OCGN ) shares gained 7% premarket on Monday after the U.S. Food and Drug Administration (FDA) cleared the firm’s investigational new drug amendment to initiate a late-stage clinical trial of its gene therapy product candidate......
MALVERN, Pa., April 08, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the U.S. Food and...
2024-04-07 04:06:09 ET Ocugen (NASDAQ: OCGN) stock price has been one of the best-performing companies in Wall Street this year. It has jumped by more than 218% in 2024, beating some of the best-known brands like Nvidia and Amazon. This surge has boosted its total market cap to over $46...
2024-04-06 06:13:00 ET 3 Top Strategies to Trade Options With Penny Stocks in 2024 Trading penny stocks through options presents a dynamic avenue for investors looking to enhance their portfolios with high-potential, yet affordable securities. The intersection of options trading and p...
News, Short Squeeze, Breakout and More Instantly...
Ocugen, Inc. Company Name:
OCGN Stock Symbol:
NYSE Market:
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 10 points on Friday. Shares of DXC Technology Company (NYS...
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Nayax Ltd. (NASDAQ:NYAX) fell...
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that dosing is complete i...